Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Valoaltistuksen optimointi likinäköisyyden ehkäisyyn ja hallintaan (LightSPAN) (LightSPAN)

tiistai 10. marraskuuta 2026 päivittänyt: Raymond P. Najjar, PhD, National University of Singapore

The goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance in children.

This trial has 3 arms namely, (1) a technical intervention arm, (2) a digital intervention arm, and (3) a control arm.

  1. technical intervention - which involves changing of classroom lighting in primary schools to ceiling lights that mimic the spectral composition of sunlight and fluctuates in intensity. Parents of children within that arm will have a sham smart-phone application (s-LightUP)
  2. digital intervention - which involves standard classroom lighting and giving parents an interventional smart-phone application (i-LightUP) that will be coupled with their child's light and activity sensor (wrist worn device ). The interventional app will provide individually tailored recommendation based on their children's behaviour (data feedback that is collected from the light and activity monitoring watch). The interventional app would then send reminder prompts/notifications to encourage parents help their children achieve required amounts of myopia-preventive light quantum target set per day.
  3. Standard care or control group which involves standard classroom lighting and parents having a sham smart-phone application (s-LightUP)

Participants will:

  • be randomised to receive either no intervention (control group), technical intervention (light intervention that mimics sunlight) or digital intervention (parents having an app that syncs with child's light and activity sensor which will provide feedback to parents to encourage and recommends increment of outdoor activities and hours).
  • have their myopia progression monitored every 6 monthly and cognitive assessment done once every 3 months over a year.
  • wear the light and activity sensor watches throughout the 1-year study period as much as possible (minimum 1 week per month) except for wet water activities such as swimming, diving and showering for research data collection purpose.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

The primary objective of the study is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. To do so, we will evaluate the effectiveness, safety and feasibility of:

  1. Arm 1: technical intervention which involves spectro-temporal refinement of classroom lighting in primary schools using full spectrum light emitting diodes (LEDs) (CCT: 4000K) in addition to intermittent fluctuations in light levels. Parents of children in that arm will have access to a sham version of the LightUP mobile application to facilitate communication with the study team and questionnaire collection during the study.

  2. Arm 2: digital intervention which involves optimization of daily light exposure using an individualised behaviour-changing smart-phone application (Interventional LightUP application) coupled with child-worn light and activity sensors to provide parents with an individually tailored recommendation to adapt their children's behaviour and provide them with the required amounts of myopia-preventive light quantum/day. + standard classroom lighting

    As compared to:

  3. Arm 3: Standard care or control group which involves standard classroom lighting and no access to the interventional version of the LightUP application. Parents of children in that arm will have access to a sham version of the LightUP mobile application to facilitate communication with the study team and questionnaire collection during the study.

Our study will also lead to the following scalable and implementable outcomes:

  1. evidence-based lighting designs and policy recommendations for classrooms;
  2. a user-friendly, smart digital eyecare companion that aligns perfectly with Singapore's Smart Nation Initiative.

A secondary objective of this study is to better understand the impact of light exposure on sleep and cognitive performance in children. This will be achieved through continuous wrist actigraphy monitoring and through cognitive assessments, performed in classrooms, using tablets (one tablet/child). The assessment consists of validated, child-adapted, higher cognitive tasks testing the following constructs: impulse control, spatial working memory, content working memory, cognitive flexibility, reaction time, and processing speed.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

396

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Opiskelupaikat

      • Singapore, Singapore, 119276
        • Rekrytointi
        • National University of Singapore, Yong Loo Lin School of Medicine, Department of Ophthalmology, Eye N Brain Research Lab
        • Päätutkija:
          • Raymond P. Najjar, PhD
        • Ottaa yhteyttä:
          • Najiya Sundus Kadavath Meethal, PhD
          • Puhelinnumero: 006591183642
          • Sähköposti: lightspan@nus.edu.sg
      • Singapore, Singapore, 469317
        • Rekrytointi
        • Bedok Green Primary School
        • Päätutkija:
          • Raymond P Najjar, PhD
        • Ottaa yhteyttä:
          • Najiya Sundus Kadavath Meethal, PhD
          • Puhelinnumero: 006591183642
          • Sähköposti: lightspan@nus.edu.sg
      • Singapore, Singapore, 649188
        • Rekrytointi
        • Westwood Primary School
        • Päätutkija:
          • Raymond P Najjar, PhD
        • Ottaa yhteyttä:
          • Najiya Sundus Kadavath Meethal, PhD
          • Puhelinnumero: 006591183642
          • Sähköposti: lightspan@nus.edu.sg
      • Singapore, Singapore, 757702
        • Rekrytointi
        • Wellington Primary School
        • Päätutkija:
          • Raymond P Najjar, PhD
        • Ottaa yhteyttä:
          • Najiya Sundus Kadavath Meethal, PhD
          • Puhelinnumero: 006591183642
          • Sähköposti: lightspan@nus.edu.sg
      • Singapore, Singapore, 297754
        • Rekrytointi
        • Marymount Convent School
        • Päätutkija:
          • Raymond P. Najjar, PhD
        • Ottaa yhteyttä:
          • Najiya Sundus Kadavath Meethal, PhD
          • Puhelinnumero: 006591183642
          • Sähköposti: lightspan@nus.edu.sg

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

7 vuotta - 10 vuotta (Lapsi)

Hyväksyy terveitä vapaaehtoisia

Joo

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Subject must meet all the inclusion criteria below to participate in this study.

    1. Written Informed Consent form from parent / legal guardian and assent from child subject has been obtained

    2. Is between 7 to 10 years of age at start of study intervention which is 2 January 2025 or 1 January 2026

    3. Studying in either Primary 2 or 3 classes of the participating school(s) in academic year 2025 or 2026.

    4. Presenting visual acuity or best corrected visual acuity (BCVA) better or equal to LogMAR 0.2 (equivalent to Snellen 6/9 or better) in each eye

    5. Normal Intraocular pressure (not more than 21mmHg)

    6. No ocular conditions (e.g., optic nerve disease, glaucoma, retinal diseases) except for refractive error.

    7. No ocular conditions affecting the accuracy of the ophthalmic examinations

    8. In good general health with no significant systemic diseases that may affect eye health

      Exclusion Criteria:

  • All subjects meeting any of the exclusion criteria at baseline will be excluded from participation.

    1. Previous or ongoing myopia control treatment (including but not limited to orthokeratology, atropine, pirenzepine, myopia control spectacle and contact lenses, light therapy)
    2. Ongoing participation in other myopia prevention and control research trials
    3. Any systemic or neurologic diseases (e.g. cancer, epilepsy, Kawasaki disease) known to affect eye health or make the participant vulnerable to the ophthalmic examinations (e.g., light flash)
    4. Any other conditions precluding adherence to the protocol including unwillingness to refrain from myopia control treatment for the duration of the study

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Ennaltaehkäisy
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Nelinkertaistaa

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Technical Intervention (n=132)

Technical refinement of classroom lighting + Sham LightUP phone application (s-LightUP)

LEDs mimicking the spectrum of sunlight (4000K) administered daily for 1 academic year, every school day, for the entire school day. The light levels generated by these LEDs will fluctuate throughout the day but will remain under 1000 lux.

Kokeellinen: Digital Intervention (n=132)

Standard classroom lighting + Interventional LightUP phone application (i-LightUP)

Smart-phone application (LightUP) will be synced daily to a child-worn light and activity sensor and will allow parents to track their children's outdoor time and exposure to brighter light levels across the day. The application will also nudge parents to increase their child's exposure to light (e.g., increase time outdoors, or sitting next to a window indoors) after school hours for better myopia prevention and control. i-LightUP aims to gradually assist parents in helping their children reach the ultimate goal of spending at least 2 hours per day in brighter light conditions (e.g., above 1000 lux).

Placebo Comparator: Control Group (n=132)

Standard care or control group which involves standard classroom lighting + Sham LightUP app (s-LightUP).

Standard Classroom Lighting + Sham LightUP phone application

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Cycloplegic auto-refraction
Aikaikkuna: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using autoref/kerato/pachy/tonometer

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Axial Length
Aikaikkuna: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using non-contact optical biometer

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Choroidal Thickness
Aikaikkuna: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using optical coherence tomography (OCT) scan

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Retinal and choroidal perfusion
Aikaikkuna: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using optical coherence tomography angiography (OCT-A) function within OCT machine used to measure choroidal thickness.

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Corneal Curvature
Aikaikkuna: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using autoref/kerato/pachy/tonometer.

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Corneal Thickness
Aikaikkuna: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Measured using autoref/kerato/pachy/tonometer.

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)
Impulse control
Aikaikkuna: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Impulse control will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Day and Night Cards" task or a similar task will be administered on tablets (one tablet per child). Impulse control will be quantified by the number of errors committed by the children during the task which involves shifting instructions and paradigms.

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Cognitive flexibility
Aikaikkuna: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Cognitive flexibility will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Day and Night Cards" task or a similar task will be administered on tablets (one tablet per child). Cognitive flexibility will be quantified by the number of errors committed by the children during the task which involves shifting instructions and paradigms.

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Spatial working memory
Aikaikkuna: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Spatial working memory will be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Eight Boxes" task or a similar task will be administered on tablets (one tablet per child). Spatial working memory will be quantified by the number of errors committed by the children during the task.

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Content working memory
Aikaikkuna: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Content working memory will also be assessed using a validated, child-adapted task developed by collaborator Dr. Evelyn Law (NUS). The "Eight Boxes" task or a similar task will be administered on tablets (one tablet per child). Content working memory will be quantified by the number of errors committed by the children during the task when remembering the content of different items in the task (e.g., strawberry, watermelon, etc.).

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Processing speed
Aikaikkuna: 1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)

Processing speed will be assessed from the previous cognitive tasks (e.g., Eight Boxes and Day and Night Cards" through the investigation of reaction time (ms) in response to the content of the tasks. The tasks will be administered on tablets (one tablet per child).

1 year, once every 3 months (Baseline, Month 3, Month 6, Month 9 , Month 12 Visit)
Sleep quantity
Aikaikkuna: 1 year or at least 1 week per month for 1 year

This is a secondary outcome and will depend on the days of wear of the activity and light trackers. Night time sleep quantity (minutes) will be collected through actigraphy watches given to participants.

1 year or at least 1 week per month for 1 year
Sleep efficiency
Aikaikkuna: 1 year or at least 1 week per month for 1 year

This is a secondary outcome and will depend on the days of wear of the activity and light trackers. Night time sleep efficiency (%) calculated as the amount of time spent asleep (in minutes) by the total amount of time in bed (in minutes) will be measured using actigraphy watches given to participants.

1 year or at least 1 week per month for 1 year
Height
Aikaikkuna: 1 year, at baseline and 12 months from baseline

Height of the participant in cm

1 year, at baseline and 12 months from baseline
Weight
Aikaikkuna: 1 year, at baseline and 12 months from baseline

Weight of the participant in Kg

1 year, at baseline and 12 months from baseline
Visual acuity
Aikaikkuna: 1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

LogMAR visual acuity test

1 year, once every 6 months (Baseline, Month 6, Month 12 Visit)

Muut tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Daytime average light levels (lux)
Aikaikkuna: 1 year or at least 1 week per month for 1 year

Daytime average light levels (lux) collected using wearable light sensors.

1 year or at least 1 week per month for 1 year
Daytime average melanopic lux
Aikaikkuna: 1 year or at least 1 week per month for 1 year

Daytime average melanopic lux collected using wearable light sensors.

1 year or at least 1 week per month for 1 year
Time spent outdoors (questionnaires)
Aikaikkuna: 1 year or at least 1 week per month for 1 year

Estimated time spent outdoors collected using questionnaires

1 year or at least 1 week per month for 1 year
Time spent outdoors (wearables)
Aikaikkuna: 1 year or at least 1 week per month for 1 year

Calculated time spent outdoors collected using the wearable light sensors.

1 year or at least 1 week per month for 1 year
Color vision
Aikaikkuna: Baseline

Color vision assessment using the Ishihara color vision test

Baseline
Cover test (distance and near)
Aikaikkuna: 1 year, repeated every 6 months

Cover test to screen for strabismus

1 year, repeated every 6 months

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Yhteistyökumppanit

Tutkijat

  • Päätutkija: Raymond P. Najjar, PhD, National University of Singapore

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Maanantai 21. lokakuuta 2024

Ensisijainen valmistuminen (Arvioitu)

Tiistai 26. tammikuuta 2027

Opintojen valmistuminen (Arvioitu)

Tiistai 26. tammikuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Tiistai 1. lokakuuta 2024

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Lauantai 5. lokakuuta 2024

Ensimmäinen Lähetetty (Todellinen)

Tiistai 8. lokakuuta 2024

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 16. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Tiistai 10. marraskuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. marraskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa